[e-med] Stratégie OMS 2004 - 2007 pour les médicaments

[hogerzeilh@who.int]

E-MED: Stratégie OMS 2004 - 2007 pour les médicaments
---------------------------------------------------------------------

[Modérateur: Pour ceux qui sont intéressés, Hans Hogerzeilh, directeur d'EDM
à l'OMS nous signale sur e-drug la publication de ce rapport disponible en
angais seulement pour l'instant. Carinne Bruneton]

-----Message d'origine-----
De : owner-e-drug@healthnet.org [mailto:owner-e-drug@healthnet.org]De la
part de hogerzeilh@who.int
Envoyé : vendredi 30 juillet 2004 07:50
À : e-drug@usa.healthnet.org
Objet : [e-drug] WHO Medicines Strategy 2004 - 2007 Reminder


E-drug: WHO Medicines Strategy 2004 - 2007 Reminder
---------------------------------------------

Dear E-Druggers,

We have pleasure to inform you that the WHO Medicines Strategy 2004 - 2007:
countries at the core  is  now available at the following link

http://www.who.int/medicines/strategy/strategy2004_2007.shtml

As you are already aware, in many countries medicines are too often
unavailable, unaffordable, unsafe, or used irrationally.  Essential
medicines save lives, reduce suffering and are a vital tool in improving and
maintaining health, more specifically for priority health diseases such as
malaria, tuberculosis, HIV/AIDS and many childhood illnesses.

The WHO Medicines Strategy 2004 - 2007 (WMS  2004 - 2007) is the result of a
global consultation process involving WHO country offices, regional offices
and headquarters, and also other key players in the medicines field.  It is
an update of WMS 2000 - 2003 which has proved to be useful for many
purposes, the most important of which has been to provide a framework for
WHO, countries and partners for action in the area of medicines. Naturally,
this latest strategy also takes into account the evolving international
context and latest developments in this area, such as access to essential
medicines in line with the U.N. Millennium Development Goals (p. 24),
relating procurement issues to the "3 by 5" Initiative (p.78), to the Global
Fund to fight AIDS, Tuberculosis and Malaria (p. 62 and 74) and to the
Prequalification Project (p. 106), the promotion of innovation based on
public health needs (p. 36), and recognizing access to essential medicines
as a human right (p. 40).

The document is meant to serve as a dynamic and active tool in the
implementation of our activities and we hope that you will also find it
useful.  The staff of the Department of Essential Drugs and Medicines Policy
(EDM) remain at your disposal for any collaboration which could further its
implementation. If you wish to receive a printed copy, kindly contact our
documentation centre at edmdoccentre@who.int <mailto:edmdoccentre@who.int>
.

Hans V. Hogerzeil
Director a.i.,
Department of Essential Drugs and Medicines Policy (EDM)
Health Technology and Pharmaceuticals (HTP)
World Health Organization
Geneva, Switzerland
Tel: +41 22 791 4443/3834
Fax: +41 22 791 4730
  hogerzeilh@who.int

--
To send a message to E-Drug, write to: e-drug@healthnet.org
To subscribe or unsubscribe, write to: majordomo@healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@healthnet.org
Information and archives: http://www.essentialdrugs.org/edrug

--
Adresse pour les messages destinés au forum E-MED:
e-med@healthnet.org
Pour répondre à un message envoyer la réponse au forum
ou directement à l'auteur.
Pour vous inscrire, vous désinscrire et consulter les archives de e-med:
http://www.essentialdrugs.org/emed/
Pour toutes autres questions addresser vos messages à:
e-med-help@healthnet.org